Motohiro Tamiya

Pretreatment advanced lung cancer inflammation index (<scp>ALI</scp>) for predicting early progression in nivolumab‐treated patients with advanced non–small cell lung cancer

Takayuki Shiroyama, Hidekazu Suzuki, Motohiro Tamiya et al. · Cancer Medicine · 2017 · 121 citations · Full text

Metastatic site as a predictor of nivolumab efficacy in patients with advanced non-small cell lung cancer: A retrospective multicenter trial

Motohiro Tamiya, Akihiro Tamiya, Takako Inoue et al. · PLoS ONE · 2018 · 105 citations · Full text

Subcutaneous Versus Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer: Primary Results From the Phase III PALOMA-3 Study

Natasha B. Leighl, Hiroaki Akamatsu, Sun Min Lim et al. · Journal of Clinical Oncology · 2024 · 94 citations · Full text

Cerebrospinal Fluid Penetration Rate and Efficacy of Afatinib in Patients with EGFR Mutation-positive Non-small Cell Lung Cancer with Leptomeningeal Carcinomatosis: A Multicenter Prospective Study

Akihiro Tamiya, Motohiro Tamiya, Takashi Nishihara et al. · Anticancer Research · 2017 · 89 citations · Full text

Clinical Evaluation of Endoscopic Bronchial Occlusion with Silicone Spigots for the Management of Persistent Pulmonary Air Leaks

Shinji Sasada, Kazuyo Tamura, Ya-shu Chang et al. · Internal Medicine · 2011 · 84 citations · Full text